Literature DB >> 16274707

Development of enzymatic probes of oxidative and nitrosative DNA damage caused by reactive nitrogen species.

Min Dong1, Viengsai Vongchampa, Lakshmaiah Gingipalli, Jean-Francois Cloutier, Yoke W Kow, Timothy O'Connor, Peter C Dedon.   

Abstract

Chronic inflammation is associated with a variety of human diseases, including cancer, with one possible mechanistic link involving over-production of nitric oxide (NO*) by activated macrophages. Subsequent reaction of NO* with superoxide in the presence of carbon dioxide yields nitrosoperoxycarbonate (ONOOCO2-), a strong oxidant that reacts with guanine in DNA to form a variety of oxidation and nitration products, such 2'-deoxy-8-oxoguanosine. Alternatively, the reaction of NO and O2 leads to the formation of N2O3, a nitrosating agent that causes nucleobase deamination to form 2'-deoxyxanthosine (dX) and 2'-deoxyoxanosine (dO) from dG; 2'-deoxyinosine (dI) from dA; and 2'-deoxyuridine (dU) from dC, in addition to abasic sites and dG-dG cross-links. The presence of both ONOOCO2- and N2O3 at sites of inflammation necessitates definition of the relative roles of oxidative and nitrosative DNA damage in the genetic toxicology of inflammation. To this end, we sought to develop enzymatic probes for oxidative and nitrosative DNA lesions as a means to quantify the two types of DNA damage in in vitro DNA damage assays, such as the comet assay and as a means to differentially map the lesions in genomic DNA by the technique of ligation-mediated PCR. On the basis of fragmentary reports in the literature, we first systematically assessed the recognition of dX and dI by a battery of DNA repair enzymes. Members of the alkylpurine DNA glycosylase family (E. coli AlkA, murine Aag, and human MPG) all showed repair activity with dX (k(cat)/Km 29 x 10(-6), 21 x 10(-6), and 7.8 x 10(-6) nM(-1) min(-1), respectively), though the activity was considerably lower than that of EndoV (8 x 10(-3) nM(-1) min(-1)). Based on these results and other published studies, we focused the development of enzymatic probes on two groups of enzymes, one with activity against oxidative damage (formamidopyrimidine-DNA glycosylase (Fpg); endonuclease III (EndoIII)) and the other with activity against nucleobase deamination products (uracil DNA glycosylase (Udg); AlkA). These combinations were assessed for recognition of DNA damage caused by N2O3 (generated with a NO*/O2 delivery system) or ONOOCO2- using a plasmid nicking assay and by LC-MS analysis. Collectively, the results indicate that a combination of AlkA and Udg react selectively with DNA containing only nitrosative damage, while Fpg and EndoIII react selectively with DNA containing oxidative base lesions caused by ONOOCO2-. The results suggest that these enzyme combinations can be used as probes to define the location and quantity of the oxidative and nitrosative DNA lesions produced by chemical mediators of inflammation in systems, such as the comet assay, ligation-mediated polymerase chain reaction, and other assays of DNA damage and repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274707     DOI: 10.1016/j.mrfmmm.2005.08.008

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Human endonuclease V as a repair enzyme for DNA deamination.

Authors:  Rongjuan Mi; Maria Alford-Zappala; Yoke W Kow; Richard P Cunningham; Weiguo Cao
Journal:  Mutat Res       Date:  2012-06-01       Impact factor: 2.433

2.  Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA.

Authors:  Bo Pang; Jose L McFaline; Nicholas E Burgis; Min Dong; Koli Taghizadeh; Matthew R Sullivan; C Eric Elmquist; Richard P Cunningham; Peter C Dedon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Mass spectrometry of structurally modified DNA.

Authors:  Natalia Tretyakova; Peter W Villalta; Srikanth Kotapati
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

Review 4.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

Review 5.  Quantitation of DNA adducts by stable isotope dilution mass spectrometry.

Authors:  Natalia Tretyakova; Melissa Goggin; Dewakar Sangaraju; Gregory Janis
Journal:  Chem Res Toxicol       Date:  2012-08-28       Impact factor: 3.739

6.  Identification of Escherichia coli mismatch-specific uracil DNA glycosylase as a robust xanthine DNA glycosylase.

Authors:  Hyun-Wook Lee; Allyn R Brice; Charles B Wright; Brian N Dominy; Weiguo Cao
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

7.  Oxanine DNA glycosylase activities in mammalian systems.

Authors:  Liang Dong; Lisiane B Meira; Tapas K Hazra; Leona D Samson; Weiguo Cao
Journal:  DNA Repair (Amst)       Date:  2007-10-22

8.  Identification of a chemical that inhibits the mycobacterial UvrABC complex in nucleotide excision repair.

Authors:  Nayef Mazloum; Melanie A Stegman; Deborah L Croteau; Bennett Van Houten; Nyoun Soo Kwon; Yan Ling; Caitlyn Dickinson; Aditya Venugopal; Mohammad Atif Towheed; Carl Nathan
Journal:  Biochemistry       Date:  2011-01-31       Impact factor: 3.162

9.  Physiological and proteomic approaches to address the active role of ozone in kiwifruit post-harvest ripening.

Authors:  Ioannis S Minas; Georgia Tanou; Maya Belghazi; Dominique Job; George A Manganaris; Athanassios Molassiotis; Miltiadis Vasilakakis
Journal:  J Exp Bot       Date:  2012-01-20       Impact factor: 6.992

10.  The Base Excision Repair system of Salmonella enterica serovar typhimurium counteracts DNA damage by host nitric oxide.

Authors:  Anthony R Richardson; Khanh C Soliven; Margaret E Castor; Penelope D Barnes; Stephen J Libby; Ferric C Fang
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.